ScreenerHero

TLSATiziana Life Sciences PLC

NAS · US · Healthcare · Biotechnology · tizianalifesciences.com
1.140USDMkt Cap: 145.08M $P/E: —

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap145.08M $
Enterprise Value131.41M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-18.43M $
Revenue/Share—
Last Price1.140 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.61
PEG—
EV/EBITDA-6.22
EV/Revenue—
P/S—
P/B14.55
EPS (TTM)-0.17
EPS (Forward)-0.20
52W Range
1.09062% of range1.170
52W High1.170 USD
52W Low1.090 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-35444.23%
ROA-160.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.85M $
CapEx (TTM)21.00K $
FCF Margin—
FCF Yield-3.78%
Net Debt-3.55M $
Net Debt/EBITDA0.17
Balance Sheet
Debt/Equity8.77
Current Ratio0.76
Quick Ratio0.72
Book Value/Sh0.0000 USD
Cash/Share0.0330 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2499:1000
Split DateJul 31, 2020
Analyst Consensus
Rating—
Target (Mean)9.131 USD
Upside (mean)+701.0%
Target Range9.131 USD – 9.131 USD
# Analysts1
Ownership
Shares Out.127.26M
Float61.89M
Insiders47.65%
Institutions1.94%
Short Interest
Short Ratio6.7d
Short % Float4.68%
Short % Out.1.34%
Shares Short1.70M
Short (prev mo.)1.57M
Technical
SMA 501.100 (+3.6%)
SMA 2001.378 (-17.3%)
Beta0.46
S&P 52W Chg21.00%
Avg Vol (30d)832.00K
Avg Vol (10d)1.43M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—